{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T18:46:15Z","timestamp":1789238775005,"version":"build-2803163510"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004708","name":"Kementerian Pendidikan Nasional","doi-asserted-by":"publisher","award":["RS-2024-00350362"],"award-info":[{"award-number":["RS-2024-00350362"]}],"id":[{"id":"10.13039\/501100004708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004708","name":"Kementerian Pendidikan Nasional","doi-asserted-by":"publisher","award":["RS-2020-NR054734"],"award-info":[{"award-number":["RS-2020-NR054734"]}],"id":[{"id":"10.13039\/501100004708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004708","name":"Kementerian Pendidikan Nasional","doi-asserted-by":"publisher","award":["RS-2024-00507224"],"award-info":[{"award-number":["RS-2024-00507224"]}],"id":[{"id":"10.13039\/501100004708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2020-NR049559"],"award-info":[{"award-number":["RS-2020-NR049559"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cca.2026.121086","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:56:23Z","timestamp":1778817383000},"page":"121086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Circulating microbial metabolites and the gut\u2013prostate axis in prostate cancer: Implications for laboratory biomarkers and therapeutic response"],"prefix":"10.1016","volume":"590","author":[{"given":"Michle William","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davini","family":"Clister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qhelen Mayline","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarysa Edelyn","family":"Wangsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystalin Natalie","family":"Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chindy","family":"Umaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amama","family":"Rani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salima","family":"Akter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonglee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosy Iara Maciel","family":"de Azambuja Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rony Abdi","family":"Syahputra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2026.121086_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"87","key":"10.1016\/j.cca.2026.121086_bb0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.eururo.2024.09.017","article-title":"Management of patients with advanced prostate cancer. Report from the 2024 advanced prostate cancer consensus conference (APCCC)","author":"Gillessen","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.cca.2026.121086_bb0015","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1056\/NEJMoa1506859","article-title":"DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer","volume":"373","author":"Mateo","year":"2015","journal-title":"New England J. Med."},{"key":"10.1016\/j.cca.2026.121086_bb0020","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41591-019-0377-7","article-title":"The microbiome, cancer, and cancer therapy","volume":"25","author":"Helmink","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.cca.2026.121086_bb0025","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The human intestinal microbiome in health and disease","volume":"375","author":"Lynch","year":"2016","journal-title":"New England J. Med."},{"issue":"359","key":"10.1016\/j.cca.2026.121086_bb0030","first-page":"97","article-title":"Gut microbiome modulates response to anti\u2013PD-1 immunotherapy in melanoma patients","volume":"2018","author":"Gopalakrishnan","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.cca.2026.121086_bb0035","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41391-018-0061-x","article-title":"Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies","volume":"21","author":"Sfanos","year":"2018","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"374","key":"10.1016\/j.cca.2026.121086_bb0040","first-page":"216","article-title":"Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis","volume":"2021","author":"Pernigoni","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.cca.2026.121086_bb0045","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jamaoncol.2018.5801","article-title":"Analysis of the prevalence of microsatellite instability in prostate cancer and response to immune checkpoint blockade","volume":"5","author":"Abida","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.cca.2026.121086_bb0050","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1186\/s12885-020-07058-y","article-title":"Immune landscape of human prostate cancer: immune evasion mechanisms and biomarkers for personalized immunotherapy","volume":"20","author":"Bou-Dargham","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cca.2026.121086_bb0055","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrc.2017.117","article-title":"Impact of oncogenic pathways on evasion of antitumour immune responses","volume":"18","author":"Spranger","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cca.2026.121086_bb0060","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/S1470-2045(18)30952-5","article-title":"Modulating the microbiome to improve therapeutic response in cancer","volume":"20","author":"McQuade","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cca.2026.121086_bb0065","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3390\/cancers15051375","article-title":"The gut-prostate axis: A new perspective of prostate cancer biology through the gut microbiome","volume":"15","author":"Fujita","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cca.2026.121086_bb0070","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/19490976.2015.1127483","article-title":"Consequences of bile salt biotransformations by intestinal bacteria","volume":"7","author":"Ridlon","year":"2016","journal-title":"Gut Microbes"},{"key":"10.1016\/j.cca.2026.121086_bb0075","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","article-title":"Gut microbiota regulation of tryptophan metabolism in health and disease","volume":"23","author":"Agus","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cca.2026.121086_bb0080","article-title":"Androgen-deprivation therapy and dietary habits influence the gut microbial environment in patients with high-risk localized prostate cancer","author":"Ishida","year":"2025","journal-title":"Prostate"},{"key":"10.1016\/j.cca.2026.121086_bb0085","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41573-025-01211-7","article-title":"The gut microbiome as a target in cancer immunotherapy: opportunities and challenges for drug development","volume":"24","author":"Elkrief","year":"2025","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.cca.2026.121086_bb0090","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/s41564-021-00928-6","article-title":"Metagenomic compendium of 189,680 DNA viruses from the human gut microbiome","volume":"6","author":"Nayfach","year":"2021","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.cca.2026.121086_bb0095","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.chom.2022.06.003","article-title":"Advances and challenges in cataloging the human gut virome","volume":"30","author":"Li","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cca.2026.121086_bb0100","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.chom.2024.09.010","article-title":"Intestinal fungal-host interactions in promoting and maintaining health","volume":"32","author":"Hill","year":"2024","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cca.2026.121086_bb0105","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2440111","article-title":"The mycobiome as integral part of the gut microbiome: crucial role of symbiotic fungi in health and disease","volume":"16","author":"Huang","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.cca.2026.121086_bb0110","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1038\/s41467-023-39149-2","article-title":"Revealing proteome-level functional redundancy in the human gut microbiome using ultra-deep metaproteomics","volume":"14","author":"Li","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.cca.2026.121086_bb0115","first-page":"49","article-title":"Microbial functional diversity and redundancy: moving forward","author":"Ramond","year":"2025","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.cca.2026.121086_bb0120","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S2468-1253(24)00390-X","article-title":"The intestinal barrier: a pivotal role in health, inflammation, and cancer","volume":"10","author":"Neurath","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cca.2026.121086_bb0125","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11739-023-03374-w","article-title":"Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review","volume":"19","author":"Di Vincenzo","year":"2024","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.cca.2026.121086_bb0130","first-page":"4","article-title":"Intestinal barrier dysfunction, LPS translocation, and disease development","author":"Ghosh","year":"2020","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.cca.2026.121086_bb0135","doi-asserted-by":"crossref","first-page":"9007","DOI":"10.1074\/jbc.RA119.007997","article-title":"Trace levels of peptidoglycan in serum underlie the NOD-dependent cytokine response to endoplasmic reticulum stress","volume":"294","author":"Molinaro","year":"2019","journal-title":"J. Biological Chem."},{"issue":"359","key":"10.1016\/j.cca.2026.121086_bb0140","first-page":"1366","article-title":"The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies","volume":"2018","author":"Zitvogel","year":"1979","journal-title":"Science"},{"issue":"359","key":"10.1016\/j.cca.2026.121086_bb0145","first-page":"91","article-title":"Gut microbiome influences efficacy of PD-1\u2013based immunotherapy against epithelial tumors","volume":"2018","author":"Routy","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.cca.2026.121086_bb0150","article-title":"Short chain fatty acids: Microbial metabolites for gut-brain axis signalling","volume":"546","author":"O\u2019Riordan","year":"2022","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.cca.2026.121086_bb0155","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cca.2026.121086_bb0160","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","volume":"66","author":"Li","year":"2014","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.cca.2026.121086_bb0165","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.3390\/cancers17233842","article-title":"Modulating prostate cancer therapy through the gut microbiome: A comprehensive review","volume":"17","author":"Magashi Ali","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"350","key":"10.1016\/j.cca.2026.121086_bb0170","first-page":"1214","article-title":"Gut microbiota and aging","volume":"2015","author":"O\u2019Toole","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.cca.2026.121086_bb0175","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41575-023-00891-z","article-title":"Effects of dietary fibre on metabolic health and obesity","volume":"21","author":"Deehan","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cca.2026.121086_bb0180","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.3390\/jpm13111602","article-title":"Metabolic disorders, the microbiome as an endocrine organ, and their relations with obesity: A literature review","volume":"13","author":"Ispas","year":"2023","journal-title":"J Pers Med"},{"key":"10.1016\/j.cca.2026.121086_bb0185","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1038\/s41598-021-82311-3","article-title":"Ethnicity influences the gut microbiota of individuals sharing a geographical location: a cross-sectional study from a middle-income country","volume":"11","author":"Dwiyanto","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.cca.2026.121086_bb0190","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.molmed.2023.07.002","article-title":"The global human gut microbiome: genes, lifestyles, and diet","volume":"29","author":"Parizadeh","year":"2023","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.cca.2026.121086_bb0195","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1136\/gutjnl-2019-320204","article-title":"Interaction between drugs and the gut microbiome","volume":"69","author":"Weersma","year":"2020","journal-title":"Gut"},{"issue":"364","key":"10.1016\/j.cca.2026.121086_bb0200","first-page":"1133","article-title":"The gut microbiota and colon cancer","volume":"2019","author":"Garrett","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.cca.2026.121086_bb0205","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2559.2011.04033.x","article-title":"Prostate cancer and inflammation: the evidence","volume":"60","author":"Sfanos","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.cca.2026.121086_bb0210","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s40168-021-01059-0","article-title":"Identifying biases and their potential solutions in human microbiome studies","volume":"9","author":"Nearing","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.cca.2026.121086_bb0215","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cca.2026.121086_bb0220","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1038\/s41388-024-03073-6","article-title":"Role of gut microbiota in the pathogenesis of castration-resistant prostate cancer: a comprehensive study using sequencing and animal models","volume":"43","author":"Lin","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.cca.2026.121086_bb0225","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.eururo.2018.06.033","article-title":"Metabolic biosynthesis pathways identified from fecal microbiome associated with prostate cancer","volume":"74","author":"Liss","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.cca.2026.121086_bb0230","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s11912-025-01641-x","article-title":"The Impact of Diet and Nutrition on Prostate Cancer \u2013 Food for Thought?","volume":"27","author":"Babakhanlou","year":"2025","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.cca.2026.121086_bb0235","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41391-023-00723-w","article-title":"Changes in the gut microbial profile during long-term androgen deprivation therapy for prostate cancer","volume":"27","author":"Wang","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.cca.2026.121086_bb0240","doi-asserted-by":"crossref","first-page":"759","DOI":"10.5534\/wjmh.220202","article-title":"Emerging Relationship between the Gut Microbiome and Prostate Cancer","volume":"41","author":"Matsushita","year":"2023","journal-title":"World J Mens Health"},{"key":"10.1016\/j.cca.2026.121086_bb0245","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.juro.2009.01.047","article-title":"Metabolic Complications of Androgen Deprivation Therapy for Prostate Cancer","volume":"181","author":"Saylor","year":"2009","journal-title":"J. Urol."},{"key":"10.1016\/j.cca.2026.121086_bb0250","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/iju.14894","article-title":"Gut microbiome and prostate cancer","volume":"29","author":"Fujita","year":"2022","journal-title":"Int. J. Urology"},{"key":"10.1016\/j.cca.2026.121086_bb0255","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41568-019-0155-3","article-title":"The cancer microbiome","volume":"19","author":"Elinav","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cca.2026.121086_bb0260","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nri.2016.42","article-title":"Gut microbiota, metabolites and host immunity","volume":"16","author":"Rooks","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cca.2026.121086_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mmr.2025.13775","article-title":"Gut microbiota as a multifaceted modulator of prostate cancer: Mechanistic insights, therapeutic opportunities and clinical challenges (Review)","volume":"33","author":"Hao","year":"2025","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.cca.2026.121086_bb0270","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3390\/ijms24021511","article-title":"Microbiome and Prostate Cancer: A Novel Target for Prevention and Treatment","volume":"24","author":"Kustrimovic","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cca.2026.121086_bb0275","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/jama.281.17.1591","article-title":"natural history of progression after PSA elevation following radical prostatectomy","volume":"281","author":"Pound","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2026.121086_bb0280","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int. J. Radiation Oncol*Biol*Phys"},{"key":"10.1016\/j.cca.2026.121086_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2022.100822","article-title":"Composition of gastrointestinal microbiota in association with treatment response in individuals with metastatic castrate resistant prostate cancer progressing on enzalutamide and initiating treatment with anti-PD-1 (pembrolizumab)","volume":"32","author":"Peiffer","year":"2022","journal-title":"Neoplasia"},{"key":"10.1016\/j.cca.2026.121086_bb0290","first-page":"11","article-title":"Editorial: The human microbiome and cancer","author":"Moran","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cca.2026.121086_bb0295","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-019-0406-6","article-title":"Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer","volume":"25","author":"Wirbel","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.cca.2026.121086_bb0300","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41586-019-1238-8","article-title":"The integrative human microbiome project","volume":"569","author":"Proctor","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.cca.2026.121086_bb0305","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13073-016-0307-y","article-title":"The healthy human microbiome","volume":"8","author":"Lloyd-Price","year":"2016","journal-title":"Genome Med"},{"key":"10.1016\/j.cca.2026.121086_bb0310","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/CIRCULATIONAHA.109.192695","article-title":"Androgen-deprivation therapy in prostate cancer and cardiovascular risk","volume":"121","author":"Levine","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2026.121086_bb0315","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature12820","article-title":"Diet rapidly and reproducibly alters the human gut microbiome","volume":"505","author":"David","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.cca.2026.121086_bb0320","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1574-6976.2010.00251.x","article-title":"Supervised classification of human microbiota","volume":"35","author":"Knights","year":"2011","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.cca.2026.121086_bb0325","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/gutjnl-2015-310376","article-title":"Proton pump inhibitors affect the gut microbiome","volume":"65","author":"Imhann","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.cca.2026.121086_bb0330","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1200\/JCO.2005.04.0756","article-title":"Defining Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy: A Proposal for a Standardized Definition","volume":"24","author":"Stephenson","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cca.2026.121086_bb0335","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1073\/pnas.1002611107","article-title":"Vaginal microbiome of reproductive-age women","volume":"108","author":"Ravel","year":"2011","journal-title":"Proceed. National Academy Sci."},{"key":"10.1016\/j.cca.2026.121086_bb0340","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.molmed.2025.03.015","article-title":"New insights into gut microbiota\u2013prostate cancer crosstalk","volume":"31","author":"Laaraj","year":"2025","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.cca.2026.121086_bb0345","first-page":"13","article-title":"Potential role of gut microbiota in prostate cancer: immunity, metabolites, pathways of action?","author":"Zha","year":"2023","journal-title":"Front. Oncol"},{"key":"10.1016\/j.cca.2026.121086_bb0350","first-page":"13","article-title":"Gut microflora modulates Th17\/treg cell differentiation in experimental autoimmune prostatitis via the short-chain fatty acid propionate","author":"Du","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.cca.2026.121086_bb0355","first-page":"9","article-title":"Cutibacterium acnes induces the expression of immunosuppressive genes in macrophages and is associated with an increase of regulatory T-cells in prostate cancer","author":"Davidsson","year":"2021","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.cca.2026.121086_bb0360","article-title":"The gut microbiota-immune-brain axis: Therapeutic implications","volume":"6","author":"O\u2019Riordan","year":"2025","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.cca.2026.121086_bb0365","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/ijc.34028","article-title":"High-fat diet promotes prostate cancer growth through histamine signaling","volume":"151","author":"Matsushita","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cca.2026.121086_bb0370","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.3390\/nu12092648","article-title":"The Crosstalk between Prostate Cancer and Microbiota Inflammation: Nutraceutical Products Are Useful to Balance This Interplay?","volume":"12","author":"Crocetto","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.cca.2026.121086_bb0375","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1158\/1055-9965.EPI-21-0766","article-title":"Gut microbiome\u2013dependent metabolic pathways and risk of lethal prostate cancer: Prospective analysis of a PLCO cancer screening trial cohort","volume":"31","author":"Reichard","year":"2022","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"key":"10.1016\/j.cca.2026.121086_bb0380","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s40168-022-01289-w","article-title":"Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-\u03baB-IL6-STAT3 axis","volume":"10","author":"Zhong","year":"2022","journal-title":"Microbiome"},{"key":"10.1016\/j.cca.2026.121086_bb0385","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1172\/JCI124332","article-title":"Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response","volume":"130","author":"Uribe-Herranz","year":"2019","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.cca.2026.121086_bb0390","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.eururo.2024.01.025","article-title":"Re: Immune system and intestinal microbiota determine efficacy of androgen deprivation therapy against prostate cancer","volume":"85","author":"Feng","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.cca.2026.121086_bb0395","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.3390\/cancers15051423","article-title":"Microbiota of urine, glans and prostate biopsies in patients with prostate cancer reveals a dysbiosis in the genitourinary system","volume":"15","author":"Gon\u00e7alves","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cca.2026.121086_bb0400","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1038\/s41467-020-18649-5","article-title":"Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients","volume":"11","author":"Daisley","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.cca.2026.121086_bb0405","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/s12967-025-06369-7","article-title":"Intratumoral microbiota-aided fusion radiomics model for predicting tumor response to neoadjuvant chemoimmunotherapy in triple-negative breast cancer","volume":"23","author":"Chen","year":"2025","journal-title":"J Transl Med"},{"key":"10.1016\/j.cca.2026.121086_bb0410","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1124\/dmd.115.065698","article-title":"Review: Mechanisms of How the Intestinal Microbiota Alters the Effects of Drugs and Bile Acids","volume":"43","author":"Klaassen","year":"2015","journal-title":"Drug Metabolism Disposition"},{"key":"10.1016\/j.cca.2026.121086_bb0415","first-page":"12","article-title":"Tryptophan Metabolite Indole-3-Aldehyde Induces AhR and c-MYC Degradation to Promote Tumor Immunogenicity. Advanced","author":"Cui","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.cca.2026.121086_bb0420","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12943-024-02164-y","article-title":"Molecular mechanisms and therapeutic significance of Tryptophan Metabolism and signaling in cancer","volume":"23","author":"Yan","year":"2024","journal-title":"Mol Cancer"},{"issue":"341","key":"10.1016\/j.cca.2026.121086_bb0425","first-page":"295","article-title":"Predicting and Manipulating Cardiac Drug Inactivation by the Human Gut Bacterium Eggerthella lenta","volume":"2013","author":"Haiser","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.cca.2026.121086_bb0430","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41522-017-0034-1","article-title":"Human microbiome signatures of differential colorectal cancer drug metabolism","volume":"3","author":"Guthrie","year":"2017","journal-title":"NPJ Biofilms Microbiomes"},{"key":"10.1016\/j.cca.2026.121086_bb0435","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.3390\/biomedicines10112676","article-title":"Exploring the association between gut and urine microbiota and prostatic disease including benign prostatic hyperplasia and prostate cancer using 16S rRNA sequencing","volume":"10","author":"Tsai","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.cca.2026.121086_bb0440","first-page":"15","article-title":"Gut microbiota derived metabolite trimethylamine N-oxide influences prostate cancer progression via the p38\/HMOX1 pathway","author":"Zhou","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cca.2026.121086_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/291546","article-title":"Obesity as a major risk factor for cancer","volume":"2013","author":"De Pergola","year":"2013","journal-title":"J Obes"},{"key":"10.1016\/j.cca.2026.121086_bb0450","first-page":"10","article-title":"Obesity, Type 2 Diabetes, and Cancer Risk. Front","author":"Scully","year":"2021","journal-title":"Oncol"},{"key":"10.1016\/j.cca.2026.121086_bb0455","doi-asserted-by":"crossref","first-page":"15354","DOI":"10.1073\/pnas.1010203108","article-title":"Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis -induced colon tumorigenesis","volume":"108","author":"Goodwin","year":"2011","journal-title":"Proc. National Academy Sci."},{"key":"10.1016\/j.cca.2026.121086_bb0460","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004191","article-title":"Immune system and intestinal microbiota determine efficacy of androgen deprivation therapy against prostate cancer","volume":"10","author":"Terrisse","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.cca.2026.121086_bb0465","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.3390\/cells12141888","article-title":"Bile acids, intestinal barrier dysfunction, and related diseases","volume":"12","author":"Shi","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.cca.2026.121086_bb0470","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1002\/pros.23897","article-title":"Metagenomic analysis reveals a rich bacterial content in high-risk prostate tumors from African men","volume":"79","author":"Feng","year":"2019","journal-title":"Prostate"},{"key":"10.1016\/j.cca.2026.121086_bb0475","doi-asserted-by":"crossref","first-page":"190","DOI":"10.15698\/mic2022.12.787","article-title":"Effects of the intestinal microbiota on prostate cancer treatment by androgen deprivation therapy","volume":"9","author":"Terrisse","year":"2022","journal-title":"Microbial Cell"},{"key":"10.1016\/j.cca.2026.121086_bb0480","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1038\/s41467-024-45332-w","article-title":"The gut microbiome-prostate cancer crosstalk is modulated by dietary polyunsaturated long-chain fatty acids","volume":"15","author":"Lachance","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.cca.2026.121086_bb0485","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41391-022-00536-3","article-title":"Gut environment changes due to androgen deprivation therapy in patients with prostate cancer","volume":"26","author":"Kure","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.cca.2026.121086_bb0490","article-title":"Glucocorticoid-induced changes of the gut microbiota and metabolic markers in healthy young men: Outcome of a randomized controlled trial","author":"Lyu","year":"2025","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.cca.2026.121086_bb0495","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/cncr.33397","article-title":"Systemic inflammation and symptomatology in patients with prostate cancer treated with androgen deprivation therapy: Preliminary findings","volume":"127","author":"Hoogland","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.cca.2026.121086_bb0500","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/NCC.0000000000001151","article-title":"Staying Strong and Healthy During Androgen Deprivation Therapy","volume":"47","author":"Myers","year":"2024","journal-title":"Cancer Nurs"},{"key":"10.1016\/j.cca.2026.121086_bb0505","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/MED.0b013e3283391fd1","article-title":"Metabolic sequelae associated with androgen deprivation therapy for prostate cancer","volume":"17","author":"Faris","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.cca.2026.121086_bb0510","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.eururo.2013.09.040","article-title":"Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: A randomised controlled trial","volume":"65","author":"Bourke","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.cca.2026.121086_bb0515","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.clnu.2020.05.016","article-title":"Mediterranean-style dietary pattern improves cancer-related fatigue and quality of life in men with prostate cancer treated with androgen deprivation therapy: A pilot randomised control trial","volume":"40","author":"Baguley","year":"2021","journal-title":"Clin. Nutrition"},{"key":"10.1016\/j.cca.2026.121086_bb0520","first-page":"22","article-title":"Life style and interaction with microbiota in prostate cancer patients undergoing radiotherapy: study protocol for a randomized controlled trial","author":"Gnagnarella","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cca.2026.121086_bb0525","article-title":"Gut microbiota as a hidden modulator of chemotherapy: implications for colorectal cancer treatment","volume":"16","author":"Sadeghloo","year":"2025","journal-title":"Discover Oncol."},{"key":"10.1016\/j.cca.2026.121086_bb0530","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/SPC.0000000000000134","article-title":"Probiotics to prevent gastrointestinal toxicity from cancer therapy: An interpretive review and call to action","volume":"9","author":"Ciorba","year":"2015","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.cca.2026.121086_bb0535","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/s41416-022-01980-7","article-title":"Exploiting dietary fibre and the gut microbiota in pelvic radiotherapy patients","volume":"127","author":"Eaton","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cca.2026.121086_bb0540","first-page":"106","article-title":"Intestinal microbiota composition is predictive of radiotherapy-induced acute gastrointestinal toxicity in prostate cancer patients","author":"Iacovacci","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cca.2026.121086_bb0545","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-021-01899-y","article-title":"The impact of pelvic radiotherapy on the gut microbiome and its role in radiation-induced diarrhoea: a systematic review","volume":"16","author":"Wang","year":"2021","journal-title":"Radiation Oncol."},{"key":"10.1016\/j.cca.2026.121086_bb0550","doi-asserted-by":"crossref","first-page":"20727","DOI":"10.1002\/cam4.6636","article-title":"Association between gut microbial change and acute gastrointestinal toxicity in patients with prostate cancer receiving definitive radiation therapy","volume":"12","author":"Jang","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.cca.2026.121086_bb0555","doi-asserted-by":"crossref","DOI":"10.1155\/mi\/1441225","article-title":"The effects of probiotic\u2013prebiotic use on acute inflammatory parameters in patients receiving pelvic radiotherapy: A prospective multicenter study","author":"Akmansu","year":"2025","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.cca.2026.121086_bb0560","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1634\/theoncologist.2019-0160","article-title":"Cumulative Antibiotic Use Significantly Decreases Efficacy of Checkpoint Inhibitors in Patients with Advanced Cancer","volume":"25","author":"Tinsley","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.cca.2026.121086_bb0565","first-page":"11","article-title":"Gut microbiota shapes cancer immunotherapy responses","author":"Lei","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"key":"10.1016\/j.cca.2026.121086_bb0570","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jaad.2024.10.083","article-title":"A retrospective cohort study of the time between prior antibiotics and checkpoint inhibitors and association with survival in melanoma patients","volume":"92","author":"Hirner","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cca.2026.121086_bb0575","first-page":"25","article-title":"Unraveling gut microbiome interferences in cancer immunotherapy: a meta-analysis of diverse drug effects","author":"Xu","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cca.2026.121086_bb0580","first-page":"15","article-title":"Comedications with immune checkpoint inhibitors: Involvement of the microbiota, impact on efficacy and practical implications","author":"Colard-Thomas","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cca.2026.121086_bb0585","first-page":"25","article-title":"Opioid Use and Gut Dysbiosis in Cancer Pain Patients","author":"Coluzzi","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cca.2026.121086_bb0590","first-page":"10","article-title":"Pain and Opioid-Induced Gut Microbial Dysbiosis","author":"Thomas","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.cca.2026.121086_bb0595","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1657865","article-title":"Proton pump inhibitors and gut microbiota dysbiosis: insights into the pathogenesis of ulcerative colitis","volume":"16","author":"Cao","year":"2025","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cca.2026.121086_bb0600","first-page":"13","article-title":"Exploring the Intestinal Microbiota Profile in Prostate Cancer Patients and Healthy Controls","author":"Cocomazzi","year":"2025","journal-title":"Microorganisms"},{"key":"10.1016\/j.cca.2026.121086_bb0605","first-page":"17","article-title":"Microbiome and Prostate Cancer: Emerging Diagnostic and Therapeutic Opportunities","author":"Kim","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.cca.2026.121086_bb0610","first-page":"12","article-title":"Taxonomic signatures of cause-specific mortality risk in human gut microbiome","author":"Salosensaari","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.cca.2026.121086_bb0615","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/s41564-020-0743-8","article-title":"Genome-wide associations of human gut microbiome variation and implications for causal inference analyses","volume":"5","author":"Hughes","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.cca.2026.121086_bb0620","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1559480","article-title":"Microbiota as diagnostic biomarkers: advancing early cancer detection and personalized therapeutic approaches through microbiome profiling","volume":"16","author":"Eslami","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.cca.2026.121086_bb0625","doi-asserted-by":"crossref","DOI":"10.1038\/s41522-025-00900-w","article-title":"Unraveling the microbial landscape in prostate cancer: pathogenesis to therapy","author":"Du","year":"2026","journal-title":"NPJ Biofilms Microbiomes"},{"key":"10.1016\/j.cca.2026.121086_bb0630","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.euros.2024.02.004","article-title":"Differences in Gut Microbiota Profiles and Microbiota Steroid Hormone Biosynthesis in Men with and Without Prostate Cancer","volume":"62","author":"Kalinen","year":"2024","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.cca.2026.121086_bb0635","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.21037\/tau-20-566","article-title":"Compositional differences of gut microbiome in matched hormone-sensitive and castration-resistant prostate cancer","volume":"9","author":"Liu","year":"2020","journal-title":"Transl Androl Urol"},{"issue":"374","key":"10.1016\/j.cca.2026.121086_bb0640","first-page":"154","article-title":"Gut bacteria enable prostate cancer growth","volume":"2021","author":"McCulloch","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.cca.2026.121086_bb0645","first-page":"43","article-title":"Gut microbiota-derived short-chain fatty acids promote prostate cancer progression via inducing cancer cell autophagy and M2 macrophage polarization","author":"Liu","year":"2023","journal-title":"Neoplasia (United States)"},{"key":"10.1016\/j.cca.2026.121086_bb0650","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1576679","article-title":"Advances in human microbiome and prostate cancer research","volume":"16","author":"Pei","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.cca.2026.121086_bb0655","first-page":"12","article-title":"Reprogramming prostate cancer through the microbiome","author":"Bautista","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.cca.2026.121086_bb0660","first-page":"14","article-title":"Gut microbiota, metabolites, and cytokines in relation to the risk of prostate cancer in the Asian population. Front","author":"Wang","year":"2024","journal-title":"Oncol"},{"key":"10.1016\/j.cca.2026.121086_bb0665","first-page":"14","article-title":"The Gut Microbiome as a Biomarker and Therapeutic Target of Immune Checkpoint Inhibitors: A Review for Oncologists","author":"Susiriwatananont","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.cca.2026.121086_bb0670","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2416912","article-title":"Fecal samples and rectal swabs adequately reflect the human colonic luminal microbiota","volume":"16","author":"Rode","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.cca.2026.121086_bb0675","first-page":"17","article-title":"Genitourinary Microbiome and Volatilome: A Pilot Study in Patients with Prostatic Adenocarcinoma Submitted to Radical Prostatectomy","author":"Musleh","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cca.2026.121086_bb0680","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s43587-021-00064-0","article-title":"Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk","volume":"1","author":"Walker","year":"2021","journal-title":"Nat Aging"},{"key":"10.1016\/j.cca.2026.121086_bb0685","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s43587-024-00590-7","article-title":"Integration of polygenic and gut metagenomic risk prediction for common diseases","volume":"4","author":"Liu","year":"2024","journal-title":"Nat Aging"},{"key":"10.1016\/j.cca.2026.121086_bb0690","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/s42255-021-00478-5","article-title":"Integrative analysis of the plasma proteome and polygenic risk of cardiometabolic diseases","volume":"3","author":"Ritchie","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/j.cca.2026.121086_bb0695","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/s41416-022-01918-z","article-title":"Applying a genetic risk score for prostate cancer to men with lower urinary tract symptoms in primary care to predict prostate cancer diagnosis: a cohort study in the UK Biobank","volume":"127","author":"Green","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cca.2026.121086_bb0700","first-page":"12","article-title":"Integrating Molecular Biomarker Inputs Into Development and Use of Clinical Cancer Therapeutics","author":"Louie","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cca.2026.121086_bb0705","first-page":"3","article-title":"Integrating biomarkers and multi-parametric MRI to provide enhanced clinical diagnosis for prostate cancer","author":"Alter","year":"2023","journal-title":"Front. Urol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126002688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126002688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:29:17Z","timestamp":1783643357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126002688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":141,"alternative-id":["S0009898126002688"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.121086","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating microbial metabolites and the gut\u2013prostate axis in prostate cancer: Implications for laboratory biomarkers and therapeutic response","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.121086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121086"}}